International Journal of Clinical Science and Medical Research

Background: Biliary tract dilatation is an important sonographic finding that frequently indicates underlying obstruction within the hepatobiliary system. Although ultrasonography effectively demonstrates structural abnormalities of the biliary tract, liver function tests provide complementary biochemical evidence of hepatobiliary dysfunction. The relationship between sonographic biliary abnormalities and biochemical liver derangement remains clinically important for diagnosis, disease severity assessment, and management, particularly in resource-limited settings where advanced imaging modalities may not be readily available.

Objective: The study aimed to evaluatethe association betweenbiliary tract dilatation detected on ultrasound and liver function test abnormalities. In addition, the study explored correlations between other sonographic hepatic findings and biochemical markers of liver dysfunction.

Methodology: This was a cross-sectional analytical study involving 338 patients who underwent abdominal ultrasonography and liver functiontesting within the study period.Ultrasound examinations were reviewed for the presence of biliary tract dilatation, liver enlargement, irregular liver outline, steatosis, liver masses, and ascites. Biochemical parameters analyzed included aspartate aminotransferase (AST), alanine aminotransferase (ALT), gamma-glutamyl transferase (GGT), alkaline phosphatase (ALP), albumin, total protein, total bilirubin, and direct bilirubin. Statistical analysis was performed using Pearson correlation and independent t-tests. Statistical significance was defined as p < 0.05.

Results: Patients with biliary tract dilatation demonstrated significantly elevated AST, ALT, GGT,ALP, total bilirubin, and direct bilirubin levels compared with patients without biliary dilatation. Most comparisonsachieved highly significant p-values below 0.001.Liver size demonstrated significant positive correlation with ALP, GGT, and AST levels. Irregular liver outline was significantly associated with elevated cholestatic and hepatocellular markers.Liver masses were associated with marked biochemical derangement, while ascites demonstrated significant association with elevated ALP and reduced albumin levels.

Conclusion: Biliary tract dilatation detected on ultrasound demonstrates a strongassociation with biochemical evidence of cholestatic and hepatocellular dysfunction. The study reinforces the close relationship between structural hepatobiliary abnormalities and biochemical liver derangement and supports the combined use of ultrasonography and liver function tests in the evaluation of hepatobiliary disease.

Biliary tract dilatation, ultrasonography, liver function tests, hepatobiliary disease, cholestatic markers, cross-sectional study

1. Maslyanko MA, SchlarbA, Romain M, O'Neal DW, Powell CR, Lustig AC. Biliary obstruction: an overview. Dig Dis Interv. 2022;6(3):163-173.
2. Onofrio FQ, Hirschfield GM. The pathophysiology of cholestasis and its relevance to clinical practice. Clin Liver Dis (Hoboken). 2020;15(3):110-114.
3. American Association for the Study of Liver Diseases (AASLD)– How to Approach Elevated Liver Enzymes?. Accessed May 29, 2026.
4. Lucius C, Flückiger A, Meier J, Möller K, Jenssen C, Braden B, et al. Ultrasound of bile ducts: an update on measurements, reference values, and their influencing factors. Diagnostics (Basel). 2025;15(7):919.
5. Mutlu Eren RI, Yıldırım Ç, Şener A, Kahraman FA, Ergin M, Gökhan Ş, et al. Diagnostic accuracy of ultrasound and computed tomography in obstructive jaundice at emergency department: a retrospective study. BMC Emerg Med. 2025;25(1):169.
6. Lee AS, PersoffJ, Lange SM. Liver functiontests. In: Mayo Clinic Medical Manual. Rochester (MN): Mayo Clinic Scientific Press; 2023. p. 373-387.
7. Jung JH, Lee KJ, Park SW, Koh DH, Lee J. Point-of-Care Testing and Biomarkers in Biliary Diseases: CurrentEvidence and FutureDirections. Journal of Clinical Medicine. 2025;14(19):6724.
8. Yuen WY, Piteša R, McHugh T, Poole G, Singh P. Liver function tests as predictors of choledocholithiasis: a scoping review. AME Surg J. 2023;3:28.
9. García-Romo JR, Shuchleib-Cung A, Barrera-Ramírez M. Liver function tests for detection of choledocholithiasis in patients with acute calculouscholecystitis. An Med ABC. 2023;68(3):153-159
10. Dündar A, Bati B, Haspolat YK, editors. Liver Biochemistry and Fatty Liver Disease. Ankara: Orient Publications; 2025.
11. Ahmed Z, Ahmed U, Walayat S, Ren J, Martin DK, Moole H, et al. Liver functiontests in identifying patients with liver disease. Clin Exp Gastroenterol. 2018;11:301-307.
12. Skelly MM, James PD, Ryder SD. Findings on liver biopsy to investigate abnormal liver function tests in the absence of diagnostic serology. J Hepatol. 2001;35(2):195-199.
13. Hanson RW, Fiskio JM, Bates DW. Abdominal cross-sectional imaging for inpatients with abnormal liver function test results. Arch Intern Med. 2001;161(15):1869-1875.
14. Allameh A, Niayesh-Mehr R, Aliarab A, Sebastiani G, Pantopoulos K. Oxidative stressin liver pathophysiology and disease. Antioxidants (Basel). 2023;12(11):2038.
15. Medscape – Biliary Obstruction Workup: Approach Considerations, Laboratory Studies, Imaging Studies. Accessed May 29, 2026.
16. European Association for the Study of the Liver (EASL)– Cirrhosis and Complications Archive. Accessed May 29, 2026.